Dov A Md Goldstein Neu Base Therapeutics, Inc. (NBSE) insider trading activity

Dov A Md Goldstein is Director of NeuBase Therapeutics, Inc.. Currently has a direct ownership of 30,000 shares of NBSE, which is worth approximately $0. The most recent transaction as insider was on Jun 18, 2021, when has been sold 8,000 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $38,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K

0% 3M change

0% 12M change

Total Value Held $0

DOV A MD GOLDSTEIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 18 2021	BUY Open market or private purchase	$38,000 $4.75 p/Share	8,000 Added 21.05%	30,000 Common Stock
Apr 26 2021	BUY Open market or private purchase	$60,000 $5.0 p/Share	12,000 Added 35.29%	22,000 Common Stock

Also insider at

GANX

Gain Therapeutics, Inc. Healthcare

Director

COYA

Coya Therapeutics, Inc.

Director

DAM